Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC4 | P56524 | 4/20 | 0.45 |
| ▸ | HDAC6 | Q9UBN7 | 4/20 | 0.45 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.45 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.45 |
| ▸ | HDAC7 | Q8WUI4 | 3/20 | 0.45 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.45 |
| ▸ | HDAC10 | Q969S8 | 3/20 | 0.45 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.45 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.45 |
| ▸ | HDAC9 | Q9UKV0 | 3/20 | 0.45 |
| ▸ | HDAC5 | Q9UQL6 | 3/20 | 0.45 |
| ▸ | EPAS1 | Q99814 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | ALOX5AP | P20292 | 2/20 | 0.33 |
| ▸ | FEN1 | P39748 | 2/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3501251 | 0.80 | HDAC3 (0.45) | HDAC4HDAC6HDAC3HDAC1HDAC7 | |
| SCHEMBL2530974 | 0.79 | POLB (0.40) | EPAS1POLBKMT2AALDH1A1CHRM1 | |
| SCHEMBL23598356 | 0.78 | HDAC1 (0.55) | HDAC4HDAC6HDAC3HDAC1HDAC7 | |
| SCHEMBL10693669 | 0.77 | POLB (0.37) | EPAS1POLBKMT2AALDH1A1CHRM1 | |
| SCHEMBL571688 | 0.77 | TET2 (0.46) | POLBKMT2AALDH1A1HTTCHRM1 | |
| SCHEMBL9780063 | 0.76 | HDAC1 (0.54) | HDAC4HDAC6HDAC3HDAC1HDAC7 | |
| Ammonia Solution, Strong SCHEMBL591415 | 0.76 | TET2 (0.45) | HDAC4HDAC6HDAC3HDAC1HDAC7 | |
| SCHEMBL22734625 | 0.75 | KMT2A (0.38) | HDAC4HDAC6HDAC3HDAC1HDAC7 | |
| SCHEMBL3400848 | 0.74 | CHRM1 (0.48) | HDAC4HDAC6POLBKMT2AALDH1A1 | |
| Trimethylammonium SCHEMBL22734573 | 0.74 | KMT2A (0.37) | EPAS1POLBKMT2AALDH1A1CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116375661-B | Water-soluble environment-sensitive fluorescent probe and preparation method and application thereof | 江苏师范大学 | 2025-03-11 | — | — | CN | claimed |
| CN-116375661-A | Water-soluble environment-sensitive fluorescent probe and preparation method and application thereof | 江苏师范大学 | 2023-07-04 | — | — | CN | claimed |
| WO-2001047485-A1 | AGENT FOR COLOURING FIBRES CONTAINING KERATIN | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2001-07-05 | — | — | WO | claimed |
| JP-6184141-A | — | — | None | — | — | JP | disclosed |
| US-12638394-B2 | Skin sensitization measuring reagent, method for measuring skin sensitization, and compound | FUJIFILM CORPORATION (JP) | 2026-05-26 | — | — | US | disclosed |
| EP-4443155-B1 | ENCAPSULATED PRE-ANALYTIC WORKFLOWS FOR FLOW-THROUGH DEVICES, LIQUID CHROMATOGRAPHY AND MASS SPECTROMETRIC ANALYSIS | WATERS TECHNOLOGIES CORP (US) | 2026-05-13 | — | — | EP | disclosed |
| US-12487210-B2 | Encapsulated pre-analytic workflows for flow-through devices, liquid chromatography and mass spectrometric analysis | WATERS TECHNOLOGIES CORPORATION (US) | 2025-12-02 | — | — | US | disclosed |
| US-20250188033-A1 | INHIBITOR OF REPLICATION PROTEIN A1 OF TRYPANOSOMA BRUCEI AND METHOD OF USE THEREOF | UNIVERSIDAD NACIONAL DE SAN MARTIN (AR) | 2025-06-12 | — | — | US | disclosed |
| CN-116375661-B | Water-soluble environment-sensitive fluorescent probe and preparation method and application thereof | 江苏师范大学 | 2025-03-11 | — | — | CN | disclosed |
| EP-4036570-B1 | REAGENT FOR MEASURING SKIN SENSITIZATION, METHOD FOR MEASURING SKIN SENSITIZATION, AND COMPOUND | FUJIFILM CORP (JP) | 2025-03-05 | — | — | EP | disclosed |
| CN-118792277-A | DNA polymerase mutant, fusion protein and application thereof | 华南理工大学 | 2024-10-18 | — | — | CN | disclosed |
| US-20110189708-A1 | METHOD FOR EVALUATING SPECIFIC INCORPORATION OF D-GLUCOSE INTO CELLS | HIROSAKI UNIVERSITY (JP) | 2011-08-04 | — | — | US | disclosed |
| EP-2325327-A1 | METHOD FOR EVALUATING SPECIFIC INCORPORATION OF D-GLUCOSE INTO CELLS | Hirosaki University (JP) | 2011-05-25 | — | — | EP | disclosed |
| US-20100099134-A1 | METHODS FOR DETECTING SULFHYDRYL-CONTAINING COMPOUNDS IN A BIOLOGICAL TEST SAMPLE | THERAVANCE BIOPHARMA R&D IP, LLC | 2010-04-22 | — | — | US | disclosed |
| EP-1948819-B1 | DIAMINE OXIDASE DETERMINATION | SCIOTEC DIAGNOSTIC TECHNOLOGIE (AT) | 2009-04-15 | — | — | EP | disclosed |
| US-20080306126-A1 | Peroxisome proliferator activated receptor treatment of hyperhomocysteinemia and its complications | FONSECA VIVIAN A | 2008-12-11 | — | — | US | disclosed |
| US-20080227116-A1 | Histaminase Determination | Missbichler, Albert (AT) | 2008-09-18 | — | — | US | disclosed |
| EP-1948819-A1 | HISTAMINASE DETERMINATION | Missbichler, Albert (AT) | 2008-07-30 | — | — | EP | disclosed |
| WO-2007056788-A1 | HISTAMINASE DETERMINATION | MISSBICHLER ALBERT (AT) | 2007-05-24 | — | — | WO | disclosed |
| JP-H06184141-A | NEW OPTICALLY ACTIVE@(3754/24)+)-AND (-)-4-(N,N-DIMETHYLAMINOSULFONYL)-7-(2-CHLOROFORMYLPYRROLIDIN-1-YL)-2,1,3-BENZOXADIAZOLE | TOKYO KASEI KOGYO KK | 1994-07-05 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110189708-A1 | METHOD FOR EVALUATING SPECIFIC INCORPORATION OF D-GLUCOSE INTO CELLS | SLC2A4, SLC2A3, SLC2A1 | HDAC4 3382/4885HDAC6 3662/4885HDAC3 2797/4885 |
| US-12638394-B2 | Skin sensitization measuring reagent, method for measuring skin sensitization, and compound | HRH1, HRH4, CUTA | HDAC4 4602/4885HDAC6 4821/4885HDAC3 4825/4885 |
| US-20250188033-A1 | INHIBITOR OF REPLICATION PROTEIN A1 OF TRYPANOSOMA BRUCEI AND METHOD OF USE THEREOF | RPA1, RPA3, POLR1A | HDAC4 2833/4885HDAC6 2687/4885HDAC3 2152/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.